COURSE DESCRIPTION:

Please join us for a conference, “Human Prion Disease in 2026: Clinical Management & Emerging Therapies,” presented by Brian S. Appleby, M.D. Dr. Appleby will identify clinical features that should prompt consideration of prion disease and appropriate diagnostic evaluation. He will review the clinical features and diagnostic testing for human prion disease and discuss prion disease transmissibility in the healthcare setting. Participants will gain an evidence-based perspective on emerging therapies and their potential impact on patient care.

TARGET AUDIENCE:

Internal Medicine Physicians, Neurologists, Pharmacists, Physician Assistants, Residents, Advanced Practice Registered Nurses, Lab Personnel, Medical Students, and all other interested healthcare providers

LEARNING OBJECTIVES:

• Identify clinical features that should prompt consideration of prion disease and appropriate diagnostic evaluation.
• Review the clinical features and appropriate diagnostic tests for human prion disease.
• Discuss prion disease transmissibility in the healthcare setting.

FACULTY AND DISCLOSURES:  
Brian S. Appleby, M.D.
Director, National Prion Disease Pathology Surveillance Center
Professor, Departments of Neurology, Psychiatry, & Pathology
Case Western Reserve University/University Hospitals Cleveland Medical Center
Cleveland, OH
 

Brian S. Appleby, M.D., faculty of this educational activity, is a consultant for Gate Bioscience, Regeneron, Eli Lilly and Company, and Nobelpharma. He receives grant/research support from Ionis Pharmaceuticals. Dr. Appleby receives royalties and is a patent beneficiary of UpToDate. He has indicated that the presentation or discussion will include off-label or unapproved product usage. All relevant financial relationships listed for this individual have been mitigated.

G. Peter Gliebus, M.D., FAAN, director for this educational activity, has no relevant financial relationships with ineligible companies* to disclose and has indicated that the presentation or discussion will not include off-label or unapproved product usage.

Kendra Kent, MS, RN, CENP, CCRN, SCRN, CNRN, TCRN, planner for this educational event, has no relevant financial relationships with ineligible companies* to disclose.

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships with ineligible companies to disclose.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Disclosure Policy and Disclaimer

ACCREDITATION STATEMENTS AND CREDITS

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.   

This activity has been approved for 1 credit hour, CE Broker Course #20-1195520, by the Florida Boards of Medicine, Osteopathic Medicine and Physician Assistants.  

This activity has also been approved for 1 credit for Nurse Practitioners, Nurses, Pharmacists and Pharmacy Techs, Occupational Therapists, Laboratory Personnel, Dietitians and Respiratory Therapists. Baptist Health South Florida CE Broker Provider #50-182.